A community pharmacy weight management programme: an evaluation of effectiveness

BMC Public Health

Janie Gordon²  Andrea Smith²  Louise McCombie¹  Naomi Brosnahan¹  Philip McLoone³  David Morrison³ 

[1] Counterweight Ltd, c/o Brodies LLP, 15 Atholl Crescent, Edinburgh EH3 8HA, Scotland, UK;NHS Fife, Pentland House, Lynebank Hospital, Halbeath Road, Dunfermline KL11 8JH, Scotland, UK;West of Scotland Cancer Surveillance Unit, Public Health Research Group, Institute of Health and Wellbeing, University of Glasgow, Glasgow G12 8RZ, Scotland, UK

关键词: BMI;    Counterweight;    Pharmacy;    Weight management;    Obesity;   

Others  :  1162398
DOI  :  10.1186/1471-2458-13-282

 received in 2012-09-21, accepted in 2013-03-15,  发布年份 2013

【 摘 要 】

Background

Community pharmacies may offer an accessible way of delivering weight-management programmes but there have been few trials that use clinically significant weight loss outcomes, objective measures of weight and follow-up to 12 months. We aimed to evaluate weight change among patients who used the Counterweight weight management programme delivered by community pharmacies.

Methods

The Counterweight Programme was introduced into community pharmacies in Fife, Scotland in 2009 for patients with a BMI ≥ 30 kg/m² or a BMI ≥ 28 kg/m² with a co-morbidity in localities in which Counterweight was not available at GP practices. The aim was to achieve an energy deficit of 500-600 kcal per day. Counterweight specialist dietitians delivered training, support and patient information materials to community pharmacies. Patient weight was measured by pharmacy staff at each weight management session. Weight data recorded at each weight management session were used to estimate weight change and attendance at 3, 6 and 12 months.

Results

Between March 2009 and July 2012, 458 patients were enrolled by the community pharmacies. Three-quarters of patients were women, mean age was 54 (SD 7.4) years and mean BMI 36.1 (SD 5.9) kg/m². Of 314 patients enrolled for at least 12 months, 32 (10.2% on an intention to treat basis) had achieved the target weight loss of ≥5%; this was 41.6% of those who attended at 12 months representing a mean weight loss of 4.1 kg. Using Last Observation Carried Forward, 15.9% achieved the target weight loss within 12 months of enrolling. There was no significant effect of sex, baseline BMI or age on weight loss.

Conclusions

The Counterweight pharmacy programme has a similar effectiveness to other primary care based weight management programmes and should be considered as part of a range of services available to a community to manage overweight and obesity.

【 授权许可】

   
2013 Morrison et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F: Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368:666-678.
• [2]World Cancer Research Fund/American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR; 2007.
• [3]Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC: Obesity, fat distribution and weight gain as risk factors for clinical diabetes. Diabetes Care 1994, 17:961-969.
• [4]World Health Organisation: Obesity and overweight Fact Sheet No. 311. Geneva: WHO; 2012. http://www.who.int/mediacentre/factsheets/fs311/en/ webcite (accessed 2 January 2013)
• [5]Campbell I: The obesity epidemic: can we turn the tide? Heart 2003, 89(Suppl 2):ii22-ii24.
• [6]Zaninotto P, Head J, Stamatakis E, Wardle H, Mindell J: Trends in obesity among adults in England from 1993 to 2004 by age and social class and projections of prevalence to 2012. J Epidemiol Community Health 2009, 63:140-146.
• [7]Butland B, Jebb SA, Kopelman PG, McPherson K, Thomas S, Mardell J, Parry V: Tackling obesities: future choices – project report. London: Government Office for Science; 2007.
• [8]NICE: Clinical Guideline 43 - Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children . London: National Institute for Clinical Excellence; 2006.
• [9]Scottish Executive: The Right Medicine: A Strategy for Pharmaceutical Care in Scotland . Edinburgh: Scottish Executive; 2002. http://www.scotland.gov.uk/Resource/Doc/158742/0043086.pdf webcite (accessed 8 August 2012)
• [10]Scottish Government: Better Health, Better Care: action plan . Edinburgh: NHS Scotland; 2007. http://www.scotland.gov.uk/Resource/Doc/206458/0054871.pdf webcite (accessed 8 August 2012)
• [11]Andronicou AM, Krska J, Hackett A, Richards J: Supply of over-the-counter weight-loss products from community pharmacies. Int J Pharm Pract 2009, 17:333-337.
• [12]Jolly K, Lewis A, Beach J, Denley J, Adab P, Deeks JJ, Daley A, Aveyard P: Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: Lighten Up randomised controlled trial. BMJ 2011, 343:d6500.
• [13]Gordon J, Watson M, Avenell A: Lightening the load? A systematic review of community pharmacy-based weight management interventions. Obes Rev 2011, 12:897-911.
• [14]SIGN: Management of Obesity: A national clinical guideline, number 115. Edinburgh: Scottish Intercollegiate Guidelines Network; 2010. http://www.sign.ac.uk/guidelines/fulltext/115/index.html webcite (accessed 22 August 2012)
• [15]Counterweight Project Team: A new evidence-based model for weight management in primary care: the Counterweight Programme. J Hum Nutr Dietet 2004, 17:191-208.
• [16]Counterweight Project Team: Evaluation of the Counterweight Programme for obesity management in primary care. Br J Gen Pract 2008, 58:548-554.
• [17]Scottish Government: Scottish Government Urban/Rural Classification 2009-2010. Edinburgh: Scottish Government; 2010. http://www.scotland.gov.uk/Resource/Doc/933/0103167.pdf webcite (accessed 25 July 2012)
• [18]Russell CA, Elia M: Nutrition screening survey in the UK in 2008: hospitals, care homes and mental health units . Redditch: British Association for Parenteral and Enteral Nutrition; 2009. http://www.bapen.org.uk/pdfs/nsw/nsw_report2008-09.pdf webcite (accessed 21 January 2013)
• [19]Barnes SA, Mallinckrodt CH, Lindborg SR, Carter MK: The impact of missing data and how it is handled on the rate of false-positive results in drug development. Pharm Stat 2008, 7:215-225.
• [20]Prochaska JO, Velicer WF: The Transtheoretical Model of Health Behavior Change. Am J Health Promot 1997, 12:38-48.
• [21]Botomino A, Bruppacher R, Krahenbuhl S, Hersberger KE: Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies. Pharm World Sci 2008, 30:222-226.
• [22]Bradley C: A feasibility study of a weight control programme in community pharmacy in Ireland. PhD thesis: an exploration of the role of community pharmacists in health promotion in Ireland. University of Dublin, School of Pharmacy & Pharmaceutical Sciences 2009, 129-163. In Gordon J, Watson M, Avenell A: Lightening the load? A systematic review of community pharmacy-based weight management interventions. Obes Reviews 2011, 12:897-911
• [23]Toubro S, Dahlager L, Hermansen L, Herborg H, Astrup A: Dietary guidelines on obesity at Danish pharmacies. Results of a 12-week course with a 1-year follow-up. Res Group Hum Nutr Frederiksberg Ugeskr Laeger 1999, 161:5308-5313.
• [24]Fonnesbæk L, Frøkjær B, Herborg H: Health promotion in community pharmacy. Country report – Denmark. Hillerød: Pharmakon; 2000. http://www.univie.ac.at/phc/pics/docs/doc84.pdf webcite (accessed 11 July 2012)
• [25]McCombie L, Lean MEJ, Haslam D, The Counterweight Research Group: Effective UK weight management services for adults. Clin Obes 2012, 2:96-102.
• [26]Jebb SA, Ahern AL, Olson AD, Aston LM, Holzapfel C, Stoll J, Amann-Gassner U, Simpson AE, Fuller NR, Pearson S, Lau NS, Mander AP, Hauner H, Caterson ID: Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 2011, 378:1485-1492.
• [27]Counterweight Project Team: The implementation of the Counterweight Programme in Scotland, UK. Fam Pract 2012, 29(Suppl 1):i139-i144.